Exact Mass: 355.05908600000004
Exact Mass Matches: 355.05908600000004
Found 179 metabolites which its exact mass value is equals to given mass value 355.05908600000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Succinylsulfathiazole
Same as: D07060
Fluchloralin
C12H13ClF3N3O4 (355.05466440000004)
2,5-diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one
2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one can be found in a number of food items such as abiyuch, saffron, natal plum, and pasta, which makes 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one a potential biomarker for the consumption of these food products. 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one may be a unique S.cerevisiae (yeast) metabolite.
succinylsulfathiazole
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AB - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013432 - Sulfathiazoles D000890 - Anti-Infective Agents > D013424 - Sulfanilamides Same as: D07060
Sulforaphane-cysteine-glycine
Avenanthramide P
Solantal
C15H18ClN3O3S (355.0757348000001)
1-Methyl ethyl 1-chloro-5-[[(5,6dihydro-2-methyl-1,4-oxathiin-3-yl)carbonyl]amino]benzoate
C16H18ClNO4S (355.0645018000001)
Clopidogrel active metabolite
C16H18ClNO4S (355.0645018000001)
Coptisine chloride
C19H14ClNO4 (355.0611314000001)
Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection. Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection.
Coptisine
C19H14NO4+.Cl- (355.0611314000001)
Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection. Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection.
N2-(2-Cyanoethyl)-N2-(4-pyridylmethyl)-3-chlorobenzo[b]thiophene-2-carboxamide
C18H14ClN3OS (355.05460640000007)
N-{2-Cyano-1-[(2,6-dichlorobenzyl)sulfanyl]-3-oxo-1-butenyl}-N,N-dimethyliminoformamide
2-[4-(1,3-Dithiolan-2-yl)phenoxy]-N-{[(isopropylamino)carbonyl]oxy}ethanimidamide
N-(5-deoxy-5-dimethylarsinoyl-beta-D-ribosyloxycarbonyl)glycine|N-[5-deoxy-5-dimethylarsinoyl-beta-ribosyloxycarbonyl]glycine
3-[2-Methyl-1,2,3,4-tetrahydro-6,7-(methylenebisoxy)isoquinoline-1-yl]-6,7-dihydroxyisobenzofuran-1(3H)-one
Methanone, (7,8-dihydro-1,3-dioxolo(4,5-g)isoquinolin-5-yl)(2-hydroxy-3,4-dimethoxyphenyl)-
Tox21_500468
C16H22BrNO3 (355.07829620000007)
Dihydro-beta-erythroidine hydrobromide is a member of indoles. Dihydro-β-erythroidine (DHβE) hydrobromide is a potent, orally active, and competitive antagonist of neuronal nAChRs. Dihydro-β-erythroidine hydrobromide shows selectivity for α4β4 and α4β2 nAChRs, with IC50s of 0.19 and 0.37 μM, respectively. Antidepressant-like activities[1][2][3]. Dihydro-β-erythroidine (DHβE) hydrobromide is a potent, orally active, and competitive antagonist of neuronal nAChRs. Dihydro-β-erythroidine hydrobromide shows selectivity for α4β4 and α4β2 nAChRs, with IC50s of 0.19 and 0.37 μM, respectively. Antidepressant-like activities[1][2][3].
Coptisine
C19H14ClNO4 (355.0611314000001)
Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection. Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection.
Isocoptisine chloride
C19H14ClNO4 (355.0611314000001)
Pseudocoptisine (Isocoptisine) chloride is a quaternary alkaloid with benzylisoquinoline skeleton, was isolated from Corydalis Tuber. Pseudocoptisine chloride inhibits acetylcholinesterase (AChE) activity with an IC50 of 12.8 μM. Anti-inflammatory and anti-amnestic effects[1][2].
MLS002172468-01!Dihydro-beta-erythroidine hydrobromide29734-68-7
C16H22BrNO3 (355.07829620000007)
methyl 3-(bromomethyl)-2-phenylquinoline-4-carboxylate
(6-Bromo-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester
(6-Bromo-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-3-yl)-carbamic acid tert-butyl ester
Thiazolidine, 3-(1-naphthalenylsulfonyl)-2-phenyl- (9CI)
N-(9-Fluorenylmethoxycarbonyl)-L-aspartic acid-1-13C
ethyl 3-(naphthalen-2-ylsulfonylamino)benzoate
C19H17NO4S (355.08782420000006)
6-BROMO-2-(2,5-DIMETHYLPHENYL)QUINOLINE-4-CARBOXYLICACID
N-(1-Naphthalenesulfonyl)-L-phenylalanine
C19H17NO4S (355.08782420000006)
6-BROMO-2-(3,4-DIMETHYLPHENYL)QUINOLINE-4-CARBOXYLICACID
2-butoxyethyl 2-(3,5,6-trichloropyridin-2-yl)oxyacetate
C13H16Cl3NO4 (355.01448660000005)
tinofedrine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine
C14H18ClN5O4 (355.10472580000004)
tert-butyl 4-(6-bromopyridin-2-yl)-1,4-diazepane-1-carboxylate
1-BOC-4-(4-BROMOPHENOXY)PIPERIDINE
C16H22BrNO3 (355.07829620000007)
Methyl [4,6-dichloro-2-(4-nitrobenzyl)pyrimidin-5-yl]acetate
C14H11Cl2N3O4 (355.01265860000007)
5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione
C18H17N3O3S (355.09905720000006)
1-BOC-4-(4-BROMOPHENYL)-4-HYDROXYPIPERIDINE
C16H22BrNO3 (355.07829620000007)
3-Fluoro-5-{5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-2-pyridinyl}be nzonitrile hydrochloride (1:1)
Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate
C16H15F2NO4S (355.06898140000004)
1-(azetidin-3-yl)-4-(4-methoxyphenyl)piperazine,trihydrochloride
3-[4-(2-Methoxyphenyl)piperazinyl]azetidine trihydrochloride
1-BOC-4-(3-bromophenoxy)piperidine
C16H22BrNO3 (355.07829620000007)
tert-butyl 4-(2-bromophenyl)-4-hydroxypiperidine-1-carboxylate
C16H22BrNO3 (355.07829620000007)
Homatropine hydrobromide
C16H22BrNO3 (355.07829620000007)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent Homatropine Bromide is an orally active muscarinic acetylcholine receptor antagonist and can be used as an anticholinergic agent[1].
WP1066
C17H14BrN3O (355.03201740000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins
tert-Butyl 4-(3-bromo-5-methylpyridin-2-yl)piperazine-1-carboxylate
N-Succinimidyl 3-(Diphenylphosphino)propionate
C19H18NO4P (355.09733980000004)
1H-Indole-1,7-dicarboxylic acid, 5-bromo-2,3-dihydro-, 1-(1,1-dimethylethyl) 7-Methyl ester
C15H18BrNO4 (355.04191280000003)
3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline
3-chloro-4-(diethylamino)benzenediazonium,hexafluorophosphate
C10H13ClF6N3P (355.04397700000004)
7-chloro-3-[2-(chloromethyl)quinolin-6-yl]quinazolin-4-one
C18H11Cl2N3O (355.02791360000003)
2-CHLORO-9-(2-3-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSYLURONIC ACID)ADENINE
Tiaramide
C15H18ClN3O3S (355.0757348000001)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3,5-dicarboxylic acid MonoMethyl ester
C16H15Cl2NO4 (355.03780900000004)
{(2z)-4-Amino-2-[(4-Methoxyphenyl)imino]-2,3-Dihydro-1,3-Thiazol-5-Yl}(4-Methoxyphenyl)methanone
C18H17N3O3S (355.09905720000006)
(E)-4-phenyl-2-(3-(thiophen-2-yl)acrylamido)thiophene-3-carboxylic acid
5-(1H-benzimidazol-2-ylmethylidene)-3-(4-fluorophenyl)-2-sulfanylidene-4-thiazolidinone
C17H10FN3OS2 (355.02493020000003)
2-[(E)-[[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]hydrazinylidene]methyl]benzoic acid
C17H13N3O4S (355.0626738000001)
(3-Anilino-5-methyl-1-pyrazolyl)-(4-bromophenyl)methanone
C17H14BrN3O (355.03201740000003)
2-[[3-(3,4-Dimethoxyphenyl)-2-oxo-1-benzopyran-7-yl]oxy]acetamide
2-[(1r)-1-Carboxy-2-(4-Hydroxyphenyl)ethyl]-1,3-Dioxoisoindoline-5-Carboxylic Acid
7-Carboxy-5-Hydroxy-12,13-Dihydro-6h-Indolo[2,3-A]pyrrolo[3,4-C]carbazole
C21H13N3O3 (355.09568680000007)
1-Deoxy-6-O-phosphono-1-[(phosphonomethyl)amino]-L-threo-hexitol
14-Oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaene-12-carboxylic acid
C21H13N3O3 (355.09568680000007)
2-{5-[2-(1H-Benzoimidazol-2-yl)-2-cyano-vinyl]-furan-2-yl}-benzoic acid
C21H13N3O3 (355.09568680000007)
N-tert-butyl-2-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]benzamide
N-[2-(1H-benzimidazol-2-yl)ethyl]-3,5-dinitrobenzamide
C16H13N5O5 (355.09166480000005)
N-[5-(2,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-phenylacetamide
C18H17N3O3S (355.09905720000006)
N-[2-(1-naphthalenyl)-1,3-benzoxazol-5-yl]-1H-1,2,4-triazole-5-carboxamide
3-(4-Bromophenyl)-1-(2-methyl-5,6,7,8-tetrahydro-3-quinolinyl)-2-propen-1-one
2-[(4-Oxo-2-pyrido[1,2-a]pyrimidinyl)methylthio]-3-pyridinecarboxylic acid propan-2-yl ester
C18H17N3O3S (355.09905720000006)
2-[(1-acetyl-2-benzimidazolyl)thio]-N-(2-methoxyphenyl)acetamide
C18H17N3O3S (355.09905720000006)
N-(2,1,3-benzothiadiazol-4-yl)-5-(3-chlorophenyl)furan-2-carboxamide
C17H10ClN3O2S (355.01822300000003)
N-(4-methylphenyl)-2-[(4E)-4-[(5-methylthiophen-2-yl)methylidene]-2,5-dioxoimidazolidin-1-yl]acetamide
C18H17N3O3S (355.09905720000006)
2-[[[5-(3-Chlorophenyl)-2-furanyl]-oxomethyl]amino]benzoic acid methyl ester
C19H14ClNO4 (355.0611314000001)
1-[2-[(4-Chlorophenyl)thio]-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
C17H22ClNO3S (355.1008852000001)
4-[[3-Cyano-4-methyl-6-(3-pyridinyl)-2-pyridinyl]thio]-3-oxobutanoic acid ethyl ester
C18H17N3O3S (355.09905720000006)
4-[(2-nitrobenzylidene)amino]-5-(phenoxymethyl)-4H-1,2,4-triazole-3-thiol
C16H13N5O3S (355.07390680000003)
2-[[3-(Methylthio)-1,2,4-thiadiazol-5-yl]thio]acetic acid (4-acetamidophenyl) ester
C13H13N3O3S3 (355.01190280000003)
N-(3-methylphenyl)-2-{(4E)-4-[(5-methylthien-2-yl)methylene]-2,5-dioxoimidazolidin-1-yl}acetamide
C18H17N3O3S (355.09905720000006)
3-chloro-4,5-dimethoxy-N-(1-naphthalenylmethyl)benzamide
2-[4-Chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide
C14H14ClN3O4S (355.03935140000004)
1-[[[2-(Difluoromethoxy)phenyl]-oxomethyl]amino]-3-(4-fluorophenyl)thiourea
5-chloro-N-(4-morpholin-4-ylphenyl)-1H-indole-2-carboxamide
(2S)-2-[2-[(1S,6S)-5-carboxy-6-hydroxycyclohexa-2,4-dien-1-yl]oxyprop-2-enoylamino]pentanedioic acid
C15H17NO9 (355.09032720000005)
[(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate;hydrobromide
C16H22BrNO3 (355.07829620000007)
3-Phenyl-4-(pentafluorobenzoyl)isoxazol-5(4H)-one
C16H6F5NO3 (355.02678260000005)
2,5-diamino-6-(5-phosphono)ribitylamino-4(3H)-pyrimidinone
A 1-deoxy-D-ribitol-5-phosphate having a (5,6-diamino-4-oxopyrimidin-2-yl)amino group at the 1-position.
S-(chloromethyl)glutathione
C11H18ClN3O6S (355.06047980000005)
An S-substituted glutathione that is glutathione in which the mercapto hydrogen has been replaced by a chloromethyl group.
VU0152099
C18H17N3O3S (355.09905720000006)
VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1]. VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1].
4-(1h-indol-3-yl)-5-oxo-6h-azepino[4,5-b]indole-2-carboxylic acid
C21H13N3O3 (355.09568680000007)
7-[(dimethylamino)methyl]-5,12-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
methyl 10-methoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
1-(1h-indole-3-carbonyl)-9h-pyrido[3,4-b]indole-3-carboxylic acid
C21H13N3O3 (355.09568680000007)
aristolochicacid i methyl ester
{"Ingredient_id": "HBIN016808","Ingredient_name": "aristolochicacid i methyl ester","Alias": "NA","Ingredient_formula": "C18H13NO7","Ingredient_Smile": "COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "355.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1718","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "96709","DrugBank_id": "NA"}
10-(6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one
methyl 8-methoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
6-hydroxy-7-methoxy-12-methyl-16,18-dioxa-12-azatetracyclo[11.7.0.0⁴,⁹.0¹⁵,¹⁹]icosa-1(20),4(9),5,7,13,15(19)-hexaene-2,3-dione
4-bromo-n-[3-(5-hydroxy-2-imino-3h-imidazol-4-ylidene)-2-methoxypropyl]-1h-pyrrole-2-carboxamide
(4s)-4-hydroxy-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,7,9(17),13,15-pentaene-3,11,12-trione
6-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h-indole-2-carboxylic acid
C15H17NO9 (355.09032720000005)
[({[(2s,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}(hydroxy)methylidene)amino]acetic acid
4-bromo-n-[(2r)-3-[(4z)-5-hydroxy-2-imino-3h-imidazol-4-ylidene]-2-methoxypropyl]-1h-pyrrole-2-carboxamide
(3s,6r,8s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,11,13,15,17(21)-pentaene-6,8,13-triol
C18H17N3O3S (355.09905720000006)
5-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2h-1,3-benzodioxole-4-carboxylic acid
{[({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)(hydroxy)methylidene]amino}acetic acid
(10r)-10-[(1s)-6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one
{8-methoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}acetic acid
5-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2h-1,3-benzodioxole-4-carboxylic acid
(3r)-3-cyano-2-methylidene-3-{[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propoxysulfonic acid
C11H17NO10S (355.05731420000006)
3-cyano-2-methylidene-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propoxysulfonic acid
C11H17NO10S (355.05731420000006)